Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    shrinc
Show Display Options
Rank Status Study
1 Active, not recruiting Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage
Condition: Intracerebral Hemorrhage
Interventions: Drug: Pioglitazone;   Drug: Placebo Control

Indicates status has not been verified in more than two years